蜜桃传媒app

Home

Joanna Przybyl (PhD)

Academic title(s): 
  • Associate Member - Department of Medicine听
  • Assistant Professor - Department of Surgery听
Joanna Przybyl (PhD)
Contact Information
Email address: 
joanna.przybyl [at] mcgill.ca
Department: 
Surgery
Division: 
Orthopaedic Surgery
Degree(s): 

PhD

Location: 
McGill University Health Centre (MUHC - Glen) - Royal Victoria Hospital
Graduate supervision: 

Currently supervising students

Group: 
Currently Recruiting
M.Sc. Students
M.Sc. Non-Thesis projects
Ph.D. Students
Research areas: 
Surgical Outcomes and Quality
Surgical Oncology
Translation and Innovation
Precision Health
Current research: 

My research group employs multi-omic high-throughput experimental methods and bioinformatic tools to discover new therapeutic targets and markers for diagnosis and classification of soft tissue sarcomas. The goal of my research is to develop clinically applicable assays and investigate new therapeutic approaches that will improve care for patients with soft tissue tumours.听

Areas of interest: 
  • Liquid biopsy in soft tissue tumors听
  • Multi-omic profiling of soft tissue tumors听
  • Immune cell infiltrates in soft tissue tumors听
Biography: 

Dr. Przybyl is an Assistant Professor in the Department of Surgery, McGill University and a Principal Investigator in the Cancer Research Program of the Research Institute of the McGill University Health Centre (RI-MUHC).鈥�
Dr. Przybyl is also an Associate Member of the Department of Pathology, McGill University, and an Associate Member of the Division of Experimental Medicine in the Department of Medicine, McGill University.听
Dr. Przybyl pursues a research program focused on the clinical applications of liquid biopsy, metabolic reprogramming and multi-omic profiling of sarcoma.鈥�
听
Dr. Joanna Przybyl received a joint Ph.D. degree in biomedical sciences from KU Leuven, Belgium and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. Her doctoral studies focused on identifying new prognostic and predictive markers for soft tissue sarcoma. She then joined the laboratory of Dr. Matt van de Rijn in the Department of Pathology at Stanford University, where she completed her postdoctoral training in computational biology. During her postdoctoral studies, Dr. Przybyl demonstrated potential clinical utility of ctDNA monitoring in patients with leiomyosarcoma and leiomyoma, discovered activation and prognostic role of hexosamine biosynthesis pathway in leiomyosarcoma, and identified macrophage infiltration in undifferentiated uterine sarcomas.鈥�

Link(s): 
Selected publications: 

Back to top